Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher Natour, Saif Abu Mouch, Yael Kopelman, Oren Shibolet, Ariel Israel
{"title":"Prevalence and Risk Factors of Type 2 Diabetes Mellitus Among Hepatitis B Virus Patients: A Large Retrospective Cohort Study.","authors":"Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher Natour, Saif Abu Mouch, Yael Kopelman, Oren Shibolet, Ariel Israel","doi":"10.7150/ijms.104839","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Hepatitis B virus (HBV) infection and type 2 diabetes mellitus (T2DM) are both major health burdens worldwide. There is a suspected link between the two conditions, but the nature of the relationship is not well understood. This study aimed to investigate the prevalence of T2DM in patients with HBV, compared to matched non-HBV patients. <b>Methods:</b> A retrospective cohort study was conducted using data from the Leumit-Health-Service (LHS) database, a major health insurance provider in Israel, covering the years 2000-2020. The study included patients with HBV infection and matched controls using propensity score matching. T2DM's prevalence was assessed and compared between both groups. <b>Results:</b> A total of 3,436 HBV carriers and 34,360 matched controls were included. T2DM's prevalence was significantly higher among HBV patients compared to the control group (22.1% vs. 19.5%; P<0.001). Through multivariate analysis, we identified age, obesity, smoking, and specific HBV-related parameters, such as chronic active disease or evidence of advanced fibrosis at presentation, as independent risk factors for T2DM in HBV patients. <b>Conclusions:</b> This study revealed a higher prevalence of T2DM in HBV patients compared to controls, and identified specific risk factors associated with T2DM in HBV patients. Enhanced screening and management of metabolic risk factors should be considered in this population.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"22 3","pages":"716-722"},"PeriodicalIF":3.2000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783066/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/ijms.104839","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hepatitis B virus (HBV) infection and type 2 diabetes mellitus (T2DM) are both major health burdens worldwide. There is a suspected link between the two conditions, but the nature of the relationship is not well understood. This study aimed to investigate the prevalence of T2DM in patients with HBV, compared to matched non-HBV patients. Methods: A retrospective cohort study was conducted using data from the Leumit-Health-Service (LHS) database, a major health insurance provider in Israel, covering the years 2000-2020. The study included patients with HBV infection and matched controls using propensity score matching. T2DM's prevalence was assessed and compared between both groups. Results: A total of 3,436 HBV carriers and 34,360 matched controls were included. T2DM's prevalence was significantly higher among HBV patients compared to the control group (22.1% vs. 19.5%; P<0.001). Through multivariate analysis, we identified age, obesity, smoking, and specific HBV-related parameters, such as chronic active disease or evidence of advanced fibrosis at presentation, as independent risk factors for T2DM in HBV patients. Conclusions: This study revealed a higher prevalence of T2DM in HBV patients compared to controls, and identified specific risk factors associated with T2DM in HBV patients. Enhanced screening and management of metabolic risk factors should be considered in this population.
背景:乙型肝炎病毒(HBV)感染和2型糖尿病(T2DM)都是世界范围内主要的健康负担。人们怀疑这两种情况之间存在联系,但这种关系的性质尚未得到很好的理解。本研究旨在调查T2DM在HBV患者中的患病率,并与匹配的非HBV患者进行比较。方法:利用以色列主要医疗保险提供商Leumit-Health-Service (LHS)数据库2000-2020年的数据进行回顾性队列研究。该研究包括HBV感染患者和使用倾向评分匹配的匹配对照组。对两组的T2DM患病率进行评估和比较。结果:共纳入3436例HBV携带者和34360例匹配对照。HBV患者的T2DM患病率明显高于对照组(22.1% vs. 19.5%;结论:本研究揭示了HBV患者中T2DM的患病率高于对照组,并确定了HBV患者中与T2DM相关的特定危险因素。应考虑在这一人群中加强代谢危险因素的筛查和管理。
期刊介绍:
Original research papers, reviews, and short research communications in any medical related area can be submitted to the Journal on the understanding that the work has not been published previously in whole or part and is not under consideration for publication elsewhere. Manuscripts in basic science and clinical medicine are both considered. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Short research communication is limited to be under 2500 words.